AGP Picks
View all

Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on October 22, 2026

Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
Annovis to Attend the CTAD 2026 with Three Presentations
Rgenta Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Trial Design for RGT-61159 in Patients with Adenoid Cystic Carcinoma (ACC)
Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development
BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET
Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Solana Company Selected as a Strategic Enterprise by the Hong Kong SAR Government
Veterans and Opioid Use Disorder  Focus of November Webinar
The Joint Corp. to Report 2026 Third Quarter Results on Thursday, November 5 and Host Conference Call and Webcast
Blue Point Brewing Co.’s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews
Newron Completes Enrollment of Pivotal Phase 3 ENIGMA-TRS 1 Study
BPGbio Appoints Jason Krause as Senior Vice President and General Counsel
Apollo Therapeutics Announces Science Translational Medicine Publication Supporting APL-9796 as a Potential Disease-Modifying Approach for Pulmonary Hypertension
Generate Biomedicines to Participate in November Investor Conferences
Sundance Biosciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of SUN-627 for Progressive Forms of Multiple Sclerosis (MS)
Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
BlossomHill Therapeutics Announces Collaboration with Foundation Medicine to Develop First Companion Diagnostic for BH-30643 in EGFR C797S Mutated Non-Small Cell Lung Cancer
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.